Schellenberg G D
Geriatric Research Education and Clinical Center (182B), Seattle Veterans Affairs Medical Center, WA 98108-1597, USA.
Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8552-9. doi: 10.1073/pnas.92.19.8552.
The genetics of Alzheimer disease (AD) are complex and not completely understood. Mutations in the amyloid precursor protein gene (APP) can cause early-onset autosomal dominant AD. In vitro studies indicate that cells expressing mutant APPs overproduce pathogenic forms of the A beta peptide, the major component of AD amyloid. However, mutations in the APP gene are responsible for 5% or less of all early-onset familial AD. A locus on chromosome 14 is responsible for AD in other early-onset AD families and represents the most severe form of the disease in terms of age of onset and rate of decline. Attempts to identify the AD3 gene by positional cloning methods are underway. At least one additional early-onset AD locus remains to be located. In late-onset AD, the apolipoprotein E gene allele epsilon 4 is a risk factor for AD. This allele appears to act as a dose-dependent age-of-onset modifier. The epsilon 2 allele of this gene may be protective. Other late-onset susceptibility factors remain to be identified.
阿尔茨海默病(AD)的遗传学机制复杂,尚未完全明确。淀粉样前体蛋白基因(APP)的突变可导致早发性常染色体显性AD。体外研究表明,表达突变型APP的细胞会过量产生Aβ肽的致病形式,Aβ肽是AD淀粉样蛋白的主要成分。然而,APP基因的突变在所有早发性家族性AD中所占比例不超过5%。14号染色体上的一个基因座与其他早发性AD家族中的AD发病相关,就发病年龄和病情进展速度而言,代表了该病最严重的形式。目前正在通过定位克隆方法来鉴定AD3基因。至少还有一个早发性AD基因座有待定位。在晚发性AD中,载脂蛋白E基因的ε4等位基因是AD的一个风险因素。该等位基因似乎作为一种剂量依赖性的发病年龄修饰因子发挥作用。该基因的ε2等位基因可能具有保护作用。其他晚发性易感因素仍有待确定。